The FDA's move toward CVSSv4 by 2027 is closer than it looks, and it is not a cosmetic change. CVSSv4 introduced subsequent-system impact, which rewards exactly the kind of chained analysis most programs are not doing yet.
A low-severity information leak, plus a reachable authentication bypass, plus a memory-safety bug, is not three medium problems you can defer. It is one critical path through the device. Score them in isolation and you will both over-patch the harmless ones and miss the chain that matters.
Start modeling attack paths now. Map initial access points, trace what each finding produces and what the next one requires, and score the chain, not the node. Manufacturers who wait until 2027 will be migrating ratings under audit pressure. The ones who start now get quieter backlogs immediately, because chaining also tells you which single fix collapses the most risk.
CVSSv4 is not more paperwork. It is the score finally matching how real attacks work.
Start with one device. We build the twin from documentation your quality system already produces, run AI discovery remotely, and show you the graph: the handful to fix, and the evidence for everything else.
One issue a month on AI, exploitability, and FDA cybersecurity review. No spam, unsubscribe anytime.